Study suggests Siemens non-invasive blood test may have a role in monitoring breast c

[News]

Siemens Healthcare announced that data from a new study published in the American Cancer Society journal Cancer, supports using the Siemens Serum HER-2/neu test to monitor patients with an aggressive type of metastatic breast cancer.

More... (http://www.news-medical.net/?id=43034)